US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ascendis Pharma A/S

216.95

-3.6500-1.65%

Post-market: 216.950.00000.00%19:04 EDT

Volume:580.80K

Turnover:127.85M

Market Cap:13.52B

PE:-49.11

High:223.91

Open:220.68

Low:216.03

Close:220.60

52wk High:248.60

52wk Low:124.06

Shares:62.32M

Float Shares:60.08M

Volume Ratio:1.65

T/O Rate:0.97%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.4176

EPS(LYR):-4.4176

ROE:-818.43%

ROA:-6.86%

PB:-71.92

PE(LYR):-49.11

Loading ...

Overview Company News Filings

Ascendis Pharma held annual general meeting with 90.16% of shares voted

European Equities Traded in the US as American Depositary Receipts Climb in Monday Trading

MT Newswires Live

Ascendis Pharma A/S EVP and CFO Scott Thomas Smith files initial beneficial ownership statement

Ascendis Pharma A/S files Form 3 for SVP and PAO Mads Bodenhoff

Ascendis Pharma Director Lisa Morrison Files Initial Beneficial Ownership Statement

Ascendis Pharma A/S director Lars Holtug files initial beneficial ownership statement

Ascendis Pharma A/S files Form 3 for EVP and Head of Research and Product Development Kennett Sprogoe

Ascendis Pharma EVP and President US Market Jay Donovan Wu files initial beneficial ownership statement

Ascendis Pharma A/S director Jan Moller Mikkelsen files initial beneficial ownership statement

Ascendis Pharma EVP Flemming Steen Jensen Files Initial Beneficial Ownership Statement

Ascendis Pharma EVP and Chief Medical Officer Aimee Shu files initial beneficial ownership statement

Ascendis Pharma’s TransCon shows efficacy and safety in Turner Syndrome

Ascendis reports 9.05 cm/year height velocity at week 52 for TransCon hGH in Turner syndrome Phase 2 trial

Ascendis Pharma Coverage Assumed by Jefferies at Buy

Ascendis Pharma assumed with a Buy at Jefferies

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Stevanato Group (STVN) and BioNTech SE (BNTX)

Ascendis Pharma A/S Publishes ApproaCH Trial Week 104 Data Presentation

RBC Lifts Price Target on Ascendis Pharma to $275 From $250, Keeps Outperform, Speculative Risk

MT Newswires Live

RBC Capital Sticks to Their Buy Rating for Ascendis Pharma (ASND)

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Intellia Therapeutics (NTLA) and Immunic (IMUX)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ASND/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ASND","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASND\",,,,,undefined,":{"symbol":"ASND","market":"US","secType":"STK","nameCN":"Ascendis Pharma A/S","latestPrice":216.95,"timestamp":1774641600000,"preClose":220.6,"halted":0,"volume":580803,"hourTrading":{"tag":"盘后","latestPrice":216.95,"preClose":216.95,"latestTime":"19:04 EDT","volume":2808,"amount":609365.17,"timestamp":1774652643717,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.01654578422484137,"floatShares":60083367,"shares":62316072,"eps":-4.417628,"marketStatus":"Market Closed","change":-3.65,"latestTime":"03-27 16:00:00 EDT","open":220.68,"high":223.905,"low":216.03,"amount":127849434.61590001,"amplitude":0.035698,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.417628,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":1,"adrRate":1,"listingDate":1422421200000,"exchange":"NASDAQ","adjPreClose":220.6,"postHourTrading":{"tag":"盘后","latestPrice":216.95,"preClose":216.95,"latestTime":"19:04 EDT","volume":2808,"amount":609365.17,"timestamp":1774652643717,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.648997,"impliedVol":0.4923,"impliedVolPercentile":0.5936},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASND\",,,,,undefined,":{"symbol":"ASND","floatShares":60083367,"roa":"-6.86%","roe":"-818.43%","lyrEps":-4.417628,"volumeRatio":1.648997,"shares":62316072,"dividePrice":0,"high":223.905,"amplitude":0.035698,"preClose":220.6,"low":216.03,"week52Low":124.06,"pbRate":"-71.92","psRate":"16.26","week52High":248.6,"institutionHeld":0,"latestPrice":216.95,"eps":-4.417628,"divideRate":0,"volume":580803,"delay":0,"ttmEps":-4.417628,"open":220.68,"prevYearClose":213.24,"prevWeekClose":221.88,"prevMonthClose":233.5,"prevQuarterClose":213.24,"fiveDayClose":221.88,"twentyDayClose":233.5,"sixtyDayClose":209.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ASND\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-11","symbol":"ASND","fiscalQuarterEnding":"2025/12","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1770786000000,"reportTimeType":"post","actualEps":-0.64},{"market":"US","date":"2025-11-12","symbol":"ASND","fiscalQuarterEnding":"2025/09","expectedEps":-0.41,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-1.17},{"market":"US","date":"2025-08-07","symbol":"ASND","fiscalQuarterEnding":"2025/06","expectedEps":-1.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.93},{"market":"US","date":"2025-05-01","symbol":"ASND","fiscalQuarterEnding":"2025/03","expectedEps":-1.56,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746072000000,"reportTimeType":"post","actualEps":-1.66},{"market":"US","date":"2025-02-12","symbol":"ASND","fiscalQuarterEnding":"2024/12","expectedEps":-1.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739336400000,"reportTimeType":"post","actualEps":-0.68}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ASND\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ASND\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":18,"updateTime":1769572800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ASND\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ASND","date":"2026-03-27","current":-49.110065,"percent":0.020358,"low":-56.197252,"twenty":-22.965697,"median":-14.542677,"eighty":-10.740794,"high":-6.283685,"avg":-18.357264,"sd":11.287335,"marketCap":13540496827},"quantilePoints":[{"date":"2021-04-01","current":-14.239588,"twenty":-34.138605,"median":-24.403644,"eighty":-17.804972,"marketCap":7019351021},{"date":"2021-04-09","current":-13.580956,"twenty":-34.05124,"median":-24.310529,"eighty":-17.775746,"marketCap":6761508296},{"date":"2021-04-16","current":-13.080256,"twenty":-33.968843,"median":-24.209048,"eighty":-17.737501,"marketCap":6564492769},{"date":"2021-04-23","current":-14.068995,"twenty":-33.864162,"median":-24.070101,"eighty":-17.700022,"marketCap":7109246084},{"date":"2021-04-30","current":-15.48417,"twenty":-33.753839,"median":-23.925154,"eighty":-17.655566,"marketCap":7803645073},{"date":"2021-05-07","current":-14.049836,"twenty":-33.628127,"median":-23.804802,"eighty":-17.581632,"marketCap":7153924469},{"date":"2021-05-14","current":-13.992401,"twenty":-33.5553,"median":-23.718956,"eighty":-17.53595,"marketCap":7115167316},{"date":"2021-05-21","current":-14.467039,"twenty":-33.35217,"median":-23.572624,"eighty":-17.49883,"marketCap":7387005680},{"date":"2021-05-28","current":-14.184361,"twenty":-33.240044,"median":-23.33481,"eighty":-17.432235,"marketCap":7233591950},{"date":"2021-06-04","current":-13.783512,"twenty":-33.167591,"median":-23.016279,"eighty":-17.407313,"marketCap":7017197846},{"date":"2021-06-11","current":-13.852311,"twenty":-32.980445,"median":-22.868537,"eighty":-17.36393,"marketCap":7011276614},{"date":"2021-06-18","current":-15.294903,"twenty":-32.76357,"median":-22.51363,"eighty":-17.264178,"marketCap":7587250970},{"date":"2021-06-25","current":-15.117851,"twenty":-32.637669,"median":-22.251319,"eighty":-17.167306,"marketCap":7554953342},{"date":"2021-07-02","current":-14.538872,"twenty":-32.339237,"median":-22.040579,"eighty":-17.100299,"marketCap":7204524085},{"date":"2021-07-09","current":-13.66833,"twenty":-32.26255,"median":-21.880968,"eighty":-17.081561,"marketCap":6785193222},{"date":"2021-07-16","current":-13.187352,"twenty":-32.177694,"median":-21.796955,"eighty":-17.019683,"marketCap":6515508034},{"date":"2021-07-23","current":-12.648813,"twenty":-32.014905,"median":-21.695721,"eighty":-16.950601,"marketCap":6225905975},{"date":"2021-07-30","current":-12.817545,"twenty":-31.845686,"median":-21.614813,"eighty":-16.913703,"marketCap":6362094304},{"date":"2021-08-06","current":-13.531364,"twenty":-31.621822,"median":-21.5498,"eighty":-16.794279,"marketCap":6660309063},{"date":"2021-08-13","current":-13.190778,"twenty":-31.498119,"median":-21.521579,"eighty":-16.681168,"marketCap":6513354859},{"date":"2021-08-20","current":-13.26408,"twenty":-31.053069,"median":-21.441984,"eighty":-16.485721,"marketCap":6483748700},{"date":"2021-08-27","current":-15.451066,"twenty":-30.552964,"median":-21.367534,"eighty":-16.407909,"marketCap":8341717212},{"date":"2021-09-03","current":-17.310645,"twenty":-30.428706,"median":-21.352703,"eighty":-16.346413,"marketCap":9418965330},{"date":"2021-09-10","current":-16.189844,"twenty":-30.428706,"median":-21.319432,"eighty":-16.296107,"marketCap":8768483895},{"date":"2021-09-17","current":-17.080111,"twenty":-30.428706,"median":-21.230017,"eighty":-16.243102,"marketCap":9180073350},{"date":"2021-09-24","current":-17.386188,"twenty":-30.428706,"median":-21.183984,"eighty":-16.243102,"marketCap":9321602560},{"date":"2021-10-01","current":-17.373879,"twenty":-30.428706,"median":-21.123882,"eighty":-16.243102,"marketCap":9222134240},{"date":"2021-10-08","current":-18.157107,"twenty":-30.428706,"median":-21.000335,"eighty":-16.243102,"marketCap":9621144300},{"date":"2021-10-15","current":-17.131611,"twenty":-30.428706,"median":-20.927013,"eighty":-16.243102,"marketCap":9099866902},{"date":"2021-10-22","current":-15.443416,"twenty":-30.428706,"median":-20.767309,"eighty":-16.177661,"marketCap":8225087523},{"date":"2021-10-29","current":-16.287021,"twenty":-30.428706,"median":-20.694874,"eighty":-16.089869,"marketCap":8623231584},{"date":"2021-11-05","current":-17.273361,"twenty":-30.428706,"median":-20.628679,"eighty":-16.089869,"marketCap":9139112531},{"date":"2021-11-12","current":-18.536152,"twenty":-30.428706,"median":-20.572898,"eighty":-16.089869,"marketCap":8837935471},{"date":"2021-11-19","current":-17.902122,"twenty":-30.349178,"median":-20.47977,"eighty":-16.089869,"marketCap":8440932665},{"date":"2021-11-26","current":-17.30965,"twenty":-30.112548,"median":-20.45204,"eighty":-16.089869,"marketCap":8157885464},{"date":"2021-12-03","current":-16.362158,"twenty":-29.857189,"median":-20.380959,"eighty":-16.089869,"marketCap":7692190570},{"date":"2021-12-10","current":-16.853703,"twenty":-29.857189,"median":-20.300515,"eighty":-16.089869,"marketCap":7941204040},{"date":"2021-12-17","current":-16.000816,"twenty":-29.857189,"median":-20.212189,"eighty":-16.020012,"marketCap":7513834299},{"date":"2021-12-23","current":-16.77763,"twenty":-29.857189,"median":-20.155183,"eighty":-16.020012,"marketCap":7907148535},{"date":"2021-12-31","current":-16.120129,"twenty":-29.857189,"median":-20.049594,"eighty":-16.020012,"marketCap":7635290643},{"date":"2022-01-07","current":-14.042624,"twenty":-29.839892,"median":-19.980256,"eighty":-15.942334,"marketCap":6632424474},{"date":"2022-01-14","current":-14.670073,"twenty":-29.839892,"median":-19.920189,"eighty":-15.716079,"marketCap":6978631810},{"date":"2022-01-21","current":-12.972874,"twenty":-29.839892,"median":-19.876598,"eighty":-15.573671,"marketCap":6127869848},{"date":"2022-01-28","current":-14.62122,"twenty":-29.839892,"median":-19.786144,"eighty":-15.516247,"marketCap":6797014847},{"date":"2022-02-04","current":-14.50631,"twenty":-29.839892,"median":-19.652538,"eighty":-15.436915,"marketCap":6913363214},{"date":"2022-02-11","current":-14.677518,"twenty":-29.839892,"median":-19.581266,"eighty":-15.347041,"marketCap":6971821174},{"date":"2022-02-18","current":-13.466571,"twenty":-29.591943,"median":-19.485906,"eighty":-15.209144,"marketCap":6356026158},{"date":"2022-02-25","current":-13.12621,"twenty":-29.404171,"median":-19.414286,"eighty":-15.117707,"marketCap":6159085264},{"date":"2022-03-04","current":-14.177375,"twenty":-29.202227,"median":-19.36732,"eighty":-15.054328,"marketCap":5935510787},{"date":"2022-03-11","current":-13.816292,"twenty":-29.07162,"median":-19.272945,"eighty":-14.959346,"marketCap":5802071102},{"date":"2022-03-18","current":-15.716255,"twenty":-28.939908,"median":-19.217636,"eighty":-14.936745,"marketCap":6668577316},{"date":"2022-03-25","current":-15.411389,"twenty":-28.844885,"median":-19.190899,"eighty":-14.936745,"marketCap":6495389639},{"date":"2022-04-01","current":-15.559542,"twenty":-28.757451,"median":-19.17389,"eighty":-14.936745,"marketCap":6587508157},{"date":"2022-04-08","current":-15.122522,"twenty":-28.605231,"median":-19.072944,"eighty":-14.936745,"marketCap":6309170742},{"date":"2022-04-14","current":-15.463474,"twenty":-28.453115,"median":-19.041314,"eighty":-14.884459,"marketCap":6410281068},{"date":"2022-04-22","current":-14.551524,"twenty":-28.374507,"median":-19.004239,"eighty":-14.799315,"marketCap":6016632439},{"date":"2022-04-29","current":-12.825416,"twenty":-28.283885,"median":-18.934719,"eighty":-14.771755,"marketCap":5184460373},{"date":"2022-05-06","current":-11.613026,"twenty":-28.168362,"median":-18.891739,"eighty":-14.706803,"marketCap":4719239266},{"date":"2022-05-13","current":-9.984926,"twenty":-28.076589,"median":-18.864911,"eighty":-14.677978,"marketCap":4638391408},{"date":"2022-05-20","current":-11.307391,"twenty":-27.984173,"median":-18.790002,"eighty":-14.651461,"marketCap":5323659051},{"date":"2022-05-27","current":-10.362949,"twenty":-27.947426,"median":-18.744016,"eighty":-14.649361,"marketCap":4954797559},{"date":"2022-06-03","current":-10.068769,"twenty":-27.947426,"median":-18.744016,"eighty":-14.649361,"marketCap":4816206322},{"date":"2022-06-10","current":-9.837168,"twenty":-27.947426,"median":-18.744016,"eighty":-14.649361,"marketCap":4619763144},{"date":"2022-06-17","current":-10.029309,"twenty":-27.947426,"median":-18.744016,"eighty":-14.649361,"marketCap":4683383946},{"date":"2022-06-24","current":-10.798489,"twenty":-27.955811,"median":-18.747509,"eighty":-14.651385,"marketCap":5083525305},{"date":"2022-07-01","current":-11.133161,"twenty":-27.955811,"median":-18.747509,"eighty":-14.651385,"marketCap":5168026464},{"date":"2022-07-08","current":-11.501599,"twenty":-27.955811,"median":-18.747509,"eighty":-14.647791,"marketCap":5224394787},{"date":"2022-07-15","current":-10.574962,"twenty":-27.955811,"median":-18.747509,"eighty":-14.619858,"marketCap":4762286157},{"date":"2022-07-22","current":-10.827381,"twenty":-27.955811,"median":-18.747509,"eighty":-14.611455,"marketCap":4939762660},{"date":"2022-07-29","current":-10.48637,"twenty":-27.955811,"median":-18.747509,"eighty":-14.611455,"marketCap":4773448202},{"date":"2022-08-05","current":-11.686251,"twenty":-27.955811,"median":-18.747509,"eighty":-14.611455,"marketCap":5296948075},{"date":"2022-08-12","current":-15.258303,"twenty":-27.955811,"median":-18.747509,"eighty":-14.619858,"marketCap":6151960660},{"date":"2022-08-19","current":-13.088553,"twenty":-27.955811,"median":-18.747509,"eighty":-14.63941,"marketCap":5167468362},{"date":"2022-08-26","current":-12.82393,"twenty":-27.955811,"median":-18.747509,"eighty":-14.63941,"marketCap":5040221058},{"date":"2022-09-02","current":-12.511949,"twenty":-27.955811,"median":-18.747509,"eighty":-14.63941,"marketCap":4935855945},{"date":"2022-09-09","current":-14.33111,"twenty":-27.955811,"median":-18.747509,"eighty":-14.63941,"marketCap":5658040204},{"date":"2022-09-16","current":-15.212187,"twenty":-27.955811,"median":-18.747509,"eighty":-14.619858,"marketCap":5995062260},{"date":"2022-09-23","current":-14.704326,"twenty":-27.955811,"median":-18.747509,"eighty":-14.63941,"marketCap":5621941828},{"date":"2022-09-30","current":-14.958022,"twenty":-27.955811,"median":-18.694608,"eighty":-14.619858,"marketCap":5767726907},{"date":"2022-10-07","current":-16.418696,"twenty":-27.955811,"median":-18.597682,"eighty":-14.611455,"marketCap":6311767776},{"date":"2022-10-14","current":-15.643642,"twenty":-27.955811,"median":-18.546958,"eighty":-14.611455,"marketCap":5995062260},{"date":"2022-10-21","current":-15.713995,"twenty":-27.955811,"median":-18.471013,"eighty":-14.611455,"marketCap":6060414192},{"date":"2022-10-28","current":-15.714051,"twenty":-27.955811,"median":-18.422988,"eighty":-14.589371,"marketCap":6144198720},{"date":"2022-11-04","current":-13.889878,"twenty":-27.955811,"median":-18.371607,"eighty":-14.551051,"marketCap":6634289132},{"date":"2022-11-11","current":-14.816192,"twenty":-27.955811,"median":-18.348112,"eighty":-14.537069,"marketCap":7373481023},{"date":"2022-11-18","current":-13.274499,"twenty":-27.955811,"median":-18.324877,"eighty":-14.513901,"marketCap":6628143167},{"date":"2022-11-25","current":-12.929127,"twenty":-27.955811,"median":-18.324877,"eighty":-14.492596,"marketCap":6477846403},{"date":"2022-12-02","current":-13.866632,"twenty":-27.955811,"median":-18.324877,"eighty":-14.463422,"marketCap":7005840612},{"date":"2022-12-09","current":-12.881379,"twenty":-27.955811,"median":-18.297625,"eighty":-14.39883,"marketCap":6540982219},{"date":"2022-12-16","current":-12.969963,"twenty":-27.955811,"median":-18.296547,"eighty":-14.350758,"marketCap":6626466995},{"date":"2022-12-23","current":-13.001454,"twenty":-27.955811,"median":-18.255178,"eighty":-14.328948,"marketCap":6653844473},{"date":"2022-12-30","current":-13.251203,"twenty":-27.955811,"median":-18.15843,"eighty":-14.287631,"marketCap":6823696578},{"date":"2023-01-06","current":-13.88229,"twenty":-27.955811,"median":-18.15843,"eighty":-14.287631,"marketCap":7099357725},{"date":"2023-01-13","current":-12.356383,"twenty":-27.955811,"median":-18.15843,"eighty":-14.287631,"marketCap":6441387593},{"date":"2023-01-20","current":-13.193213,"twenty":-27.955811,"median":-18.15843,"eighty":-14.273409,"marketCap":6888807283},{"date":"2023-01-27","current":-13.114667,"twenty":-27.955811,"median":-18.15843,"eighty":-14.249518,"marketCap":6859688605},{"date":"2023-02-03","current":-12.433541,"twenty":-27.955811,"median":-18.15843,"eighty":-14.221956,"marketCap":6501304873},{"date":"2023-02-10","current":-12.400608,"twenty":-27.955811,"median":-18.15843,"eighty":-14.198427,"marketCap":6380910339},{"date":"2023-02-17","current":-10.511711,"twenty":-27.955811,"median":-18.15843,"eighty":-14.159248,"marketCap":6536966030},{"date":"2023-02-24","current":-10.326898,"twenty":-27.955811,"median":-18.146338,"eighty":-14.123953,"marketCap":6354278424},{"date":"2023-03-03","current":-10.345133,"twenty":-27.955811,"median":-18.097908,"eighty":-14.094932,"marketCap":6395186999},{"date":"2023-03-10","current":-9.568888,"twenty":-27.955811,"median":-18.039078,"eighty":-14.053275,"marketCap":5951917378},{"date":"2023-03-17","current":-9.777457,"twenty":-27.955811,"median":-18.011685,"eighty":-14.0184,"marketCap":6078407412},{"date":"2023-03-24","current":-9.398575,"twenty":-27.955811,"median":-17.994272,"eighty":-13.932842,"marketCap":5896291266},{"date":"2023-03-31","current":-9.5125,"twenty":-27.947426,"median":-17.969708,"eighty":-13.865667,"marketCap":6027414759},{"date":"2023-04-06","current":-6.283685,"twenty":-27.947426,"median":-17.969708,"eighty":-13.841688,"marketCap":4001974041},{"date":"2023-04-14","current":-7.201403,"twenty":-27.955811,"median":-17.976848,"eighty":-13.817394,"marketCap":4641705247},{"date":"2023-04-21","current":-7.296307,"twenty":-27.955811,"median":-17.962569,"eighty":-13.754676,"marketCap":4667283252},{"date":"2023-04-28","current":-6.732417,"twenty":-27.955811,"median":-17.962569,"eighty":-13.71092,"marketCap":4327461184},{"date":"2023-05-05","current":-8.446623,"twenty":-27.955811,"median":-17.931459,"eighty":-13.571569,"marketCap":5284809377},{"date":"2023-05-12","current":-8.682804,"twenty":-27.964197,"median":-17.903569,"eighty":-13.544525,"marketCap":5391056476},{"date":"2023-05-19","current":-8.205556,"twenty":-27.972582,"median":-17.84903,"eighty":-13.532291,"marketCap":5023969940},{"date":"2023-05-26","current":-8.154362,"twenty":-27.972582,"median":-17.804262,"eighty":-13.443227,"marketCap":4972813930},{"date":"2023-06-02","current":-8.099575,"twenty":-27.972582,"median":-17.774765,"eighty":-13.379358,"marketCap":4944706232},{"date":"2023-06-09","current":-8.461637,"twenty":-27.972582,"median":-17.75578,"eighty":-13.359333,"marketCap":5184108718},{"date":"2023-06-16","current":-8.368476,"twenty":-27.980967,"median":-17.74711,"eighty":-13.343143,"marketCap":5198163887},{"date":"2023-06-23","current":-8.017188,"twenty":-27.984173,"median":-17.75578,"eighty":-13.331596,"marketCap":4996331653},{"date":"2023-06-30","current":-7.946371,"twenty":-27.98738,"median":-17.764862,"eighty":-13.301445,"marketCap":4919309325},{"date":"2023-07-07","current":-7.891043,"twenty":-27.98738,"median":-17.74711,"eighty":-13.289443,"marketCap":4873915001},{"date":"2023-07-14","current":-7.732097,"twenty":-27.98738,"median":-17.724083,"eighty":-13.262449,"marketCap":4921141770},{"date":"2023-07-21","current":-7.989428,"twenty":-27.98738,"median":-17.643003,"eighty":-13.239605,"marketCap":5063384300},{"date":"2023-07-28","current":-7.876699,"twenty":-27.98738,"median":-17.643003,"eighty":-13.192293,"marketCap":4922266217},{"date":"2023-08-04","current":-8.517492,"twenty":-27.98738,"median":-17.643003,"eighty":-13.15152,"marketCap":5302891486},{"date":"2023-08-11","current":-8.126006,"twenty":-27.98738,"median":-17.643003,"eighty":-13.113949,"marketCap":5089808802},{"date":"2023-08-18","current":-7.991704,"twenty":-27.98738,"median":-17.559252,"eighty":-13.079069,"marketCap":4943068484},{"date":"2023-08-25","current":-8.752256,"twenty":-27.98738,"median":-17.442018,"eighty":-13.009616,"marketCap":5390036119},{"date":"2023-09-01","current":-8.935936,"twenty":-27.98738,"median":-17.392059,"eighty":-12.978786,"marketCap":5510914158},{"date":"2023-09-08","current":-8.898728,"twenty":-27.98738,"median":-17.374511,"eighty":-12.956615,"marketCap":5796523666},{"date":"2023-09-15","current":-8.952406,"twenty":-27.98738,"median":-17.311127,"eighty":-12.879471,"marketCap":5812828146},{"date":"2023-09-22","current":-8.26667,"twenty":-27.98738,"median":-17.213144,"eighty":-12.821376,"marketCap":5365860511},{"date":"2023-09-29","current":-8.299648,"twenty":-27.98738,"median":-17.137339,"eighty":-12.786988,"marketCap":5338311562},{"date":"2023-10-06","current":-7.942079,"twenty":-27.98738,"median":-17.064875,"eighty":-12.70048,"marketCap":5090038308},{"date":"2023-10-13","current":-8.19916,"twenty":-27.98738,"median":-17.034448,"eighty":-12.637686,"marketCap":5265888332},{"date":"2023-10-20","current":-7.897341,"twenty":-27.98738,"median":-16.950238,"eighty":-12.506327,"marketCap":5084383966},{"date":"2023-10-27","current":-7.850435,"twenty":-27.996999,"median":-16.897477,"eighty":-12.433541,"marketCap":5032364024},{"date":"2023-11-03","current":-7.812981,"twenty":-27.996999,"median":-16.795286,"eighty":-12.356383,"marketCap":5048761614},{"date":"2023-11-10","current":-8.072859,"twenty":-27.996999,"median":-16.751159,"eighty":-12.27544,"marketCap":5205952311},{"date":"2023-11-17","current":-8.084953,"twenty":-27.996999,"median":-16.679308,"eighty":-12.105765,"marketCap":5286809396},{"date":"2023-11-24","current":-7.945324,"twenty":-27.996999,"median":-16.679308,"eighty":-11.643956,"marketCap":5215901091},{"date":"2023-12-01","current":-8.649846,"twenty":-27.996999,"median":-16.628942,"eighty":-11.389165,"marketCap":5679021537},{"date":"2023-12-08","current":-9.472938,"twenty":-27.993793,"median":-16.54651,"eighty":-11.216927,"marketCap":6152320454},{"date":"2023-12-15","current":-10.265212,"twenty":-27.993793,"median":-16.50434,"eighty":-11.097597,"marketCap":6794419113},{"date":"2023-12-22","current":-10.411937,"twenty":-27.993793,"median":-16.401961,"eighty":-10.980071,"marketCap":6890019549},{"date":"2023-12-29","current":-10.804649,"twenty":-27.996999,"median":-16.362158,"eighty":-10.877852,"marketCap":7204539324},{"date":"2024-01-05","current":-10.618051,"twenty":-28.003343,"median":-16.262519,"eighty":-10.812319,"marketCap":7004853208},{"date":"2024-01-12","current":-11.62417,"twenty":-28.003343,"median":-16.212397,"eighty":-10.812319,"marketCap":7661045546},{"date":"2024-01-19","current":-11.501354,"twenty":-28.009687,"median":-16.10121,"eighty":-10.810401,"marketCap":7522453198},{"date":"2024-01-26","current":-11.423448,"twenty":-28.003343,"median":-16.034045,"eighty":-10.812319,"marketCap":7452874183},{"date":"2024-02-02","current":-12.26812,"twenty":-28.003343,"median":-15.892322,"eighty":-10.812319,"marketCap":8011769037},{"date":"2024-02-09","current":-15.212102,"twenty":-28.003343,"median":-15.772088,"eighty":-10.812319,"marketCap":7883553111},{"date":"2024-02-16","current":-16.08924,"twenty":-28.003343,"median":-15.748423,"eighty":-10.812319,"marketCap":8333637472},{"date":"2024-02-23","current":-17.198545,"twenty":-28.003343,"median":-15.748423,"eighty":-10.812319,"marketCap":8956395707},{"date":"2024-03-01","current":-16.073996,"twenty":-27.996999,"median":-15.749583,"eighty":-10.814236,"marketCap":8365341527},{"date":"2024-03-08","current":-15.739262,"twenty":-27.914563,"median":-15.739262,"eighty":-10.814236,"marketCap":8281552237},{"date":"2024-03-15","current":-16.182326,"twenty":-27.847417,"median":-15.739262,"eighty":-10.814236,"marketCap":8485930167},{"date":"2024-03-22","current":-15.831004,"twenty":-27.761701,"median":-15.716255,"eighty":-10.814236,"marketCap":8276456943},{"date":"2024-03-28","current":-16.307757,"twenty":-27.731992,"median":-15.715626,"eighty":-10.814236,"marketCap":8480579820},{"date":"2024-04-05","current":-16.129857,"twenty":-27.647462,"median":-15.714838,"eighty":-10.812319,"marketCap":8435446042},{"date":"2024-04-12","current":-16.73499,"twenty":-27.583364,"median":-15.714838,"eighty":-10.812319,"marketCap":8629121369},{"date":"2024-04-19","current":-15.678934,"twenty":-27.500617,"median":-15.714023,"eighty":-10.812319,"marketCap":8049238014},{"date":"2024-04-26","current":-15.168374,"twenty":-27.442493,"median":-15.711287,"eighty":-10.814236,"marketCap":7822997809},{"date":"2024-05-03","current":-15.022563,"twenty":-27.394574,"median":-15.643642,"eighty":-10.814236,"marketCap":8061235601},{"date":"2024-05-10","current":-14.073933,"twenty":-27.308275,"median":-15.618754,"eighty":-10.814236,"marketCap":7605898622},{"date":"2024-05-17","current":-12.91619,"twenty":-27.226828,"median":-15.534997,"eighty":-10.814236,"marketCap":7041682209},{"date":"2024-05-24","current":-13.672901,"twenty":-27.153912,"median":-15.477149,"eighty":-10.814236,"marketCap":7422761264},{"date":"2024-05-31","current":-14.49229,"twenty":-27.094752,"median":-15.463474,"eighty":-10.814236,"marketCap":7882096228},{"date":"2024-06-07","current":-14.552327,"twenty":-26.958863,"median":-15.410909,"eighty":-10.814236,"marketCap":7942308676},{"date":"2024-06-14","current":-13.579514,"twenty":-26.88788,"median":-15.356496,"eighty":-10.812319,"marketCap":7331592551},{"date":"2024-06-21","current":-12.977214,"twenty":-26.765804,"median":-15.258303,"eighty":-10.810401,"marketCap":6974877081},{"date":"2024-06-28","current":-14.461515,"twenty":-26.558478,"median":-15.216022,"eighty":-10.804649,"marketCap":7765156691},{"date":"2024-07-05","current":-14.191597,"twenty":-26.533374,"median":-15.190262,"eighty":-10.804649,"marketCap":7695189991},{"date":"2024-07-12","current":-14.27428,"twenty":-26.508986,"median":-15.120186,"eighty":-10.804649,"marketCap":7782935115},{"date":"2024-07-15","current":-14.465145,"twenty":-26.431235,"median":-15.089268,"eighty":-10.804649,"marketCap":7918854032},{"date":"2024-08-02","current":-14.47449,"twenty":-26.176901,"median":-15.006461,"eighty":-10.749788,"marketCap":7829961913},{"date":"2024-08-09","current":-13.203321,"twenty":-26.078777,"median":-14.955173,"eighty":-10.749788,"marketCap":7224922008},{"date":"2024-08-16","current":-14.52139,"twenty":-25.747893,"median":-14.900226,"eighty":-10.749788,"marketCap":8000290683},{"date":"2024-08-23","current":-14.348966,"twenty":-25.537053,"median":-14.816192,"eighty":-10.749788,"marketCap":7993982210},{"date":"2024-08-30","current":-14.239132,"twenty":-25.376377,"median":-14.761401,"eighty":-10.749788,"marketCap":7910825066},{"date":"2024-09-06","current":-12.575294,"twenty":-25.204444,"median":-14.709505,"eighty":-10.749788,"marketCap":6824620726},{"date":"2024-09-13","current":-12.082843,"twenty":-24.965218,"median":-14.685047,"eighty":-10.749788,"marketCap":6526975502},{"date":"2024-09-20","current":-16.138372,"twenty":-24.89955,"median":-14.677518,"eighty":-10.749788,"marketCap":8799277548},{"date":"2024-09-27","current":-16.065853,"twenty":-24.697036,"median":-14.677518,"eighty":-10.749788,"marketCap":8790088396},{"date":"2024-10-04","current":-15.593724,"twenty":-24.697036,"median":-14.677518,"eighty":-10.749788,"marketCap":8407729095},{"date":"2024-10-11","current":-14.536324,"twenty":-24.697036,"median":-14.673982,"eighty":-10.749788,"marketCap":7774241454},{"date":"2024-10-18","current":-14.279832,"twenty":-24.697036,"median":-14.62122,"eighty":-10.749788,"marketCap":7569254037},{"date":"2024-10-25","current":-14.671416,"twenty":-24.615282,"median":-14.597641,"eighty":-10.749788,"marketCap":7757499341},{"date":"2024-10-31","current":-13.807171,"twenty":-24.38359,"median":-14.567264,"eighty":-10.749788,"marketCap":7338578839},{"date":"2024-11-08","current":-14.323048,"twenty":-24.067565,"median":-14.547159,"eighty":-10.745536,"marketCap":7562680391},{"date":"2024-11-15","current":-14.340744,"twenty":-22.828564,"median":-14.538333,"eighty":-10.745536,"marketCap":7427024251},{"date":"2024-11-22","current":-16.381869,"twenty":-21.818062,"median":-14.538333,"eighty":-10.745536,"marketCap":7329017172},{"date":"2024-11-29","current":-18.074176,"twenty":-21.511458,"median":-14.538333,"eighty":-10.745536,"marketCap":8132197137},{"date":"2024-12-06","current":-17.508257,"twenty":-21.254954,"median":-14.538333,"eighty":-10.745536,"marketCap":7892557876},{"date":"2024-12-13","current":-17.452314,"twenty":-20.923585,"median":-14.538333,"eighty":-10.745536,"marketCap":7807100484},{"date":"2024-12-20","current":-18.589951,"twenty":-20.700227,"median":-14.538333,"eighty":-10.745536,"marketCap":8231399424},{"date":"2024-12-27","current":-18.877828,"twenty":-20.554656,"median":-14.538333,"eighty":-10.745536,"marketCap":8384983688},{"date":"2025-01-03","current":-18.855148,"twenty":-20.394227,"median":-14.538333,"eighty":-10.745536,"marketCap":8246937132},{"date":"2025-01-10","current":-18.297678,"twenty":-20.164444,"median":-14.537794,"eighty":-10.741285,"marketCap":8033592454},{"date":"2025-01-17","current":-17.915201,"twenty":-19.885961,"median":-14.537794,"eighty":-10.741285,"marketCap":7865665690},{"date":"2025-01-24","current":-17.171929,"twenty":-19.868162,"median":-14.537794,"eighty":-10.741285,"marketCap":7624890939},{"date":"2025-01-31","current":-17.124916,"twenty":-19.576677,"median":-14.537794,"eighty":-10.741285,"marketCap":7613527466},{"date":"2025-02-07","current":-16.897094,"twenty":-19.381495,"median":-14.537794,"eighty":-10.741285,"marketCap":7477165780},{"date":"2025-02-14","current":-21.582035,"twenty":-19.188375,"median":-14.537794,"eighty":-10.741285,"marketCap":8522007294},{"date":"2025-02-21","current":-23.380772,"twenty":-19.188375,"median":-14.537794,"eighty":-10.741285,"marketCap":9250623688},{"date":"2025-02-28","current":-23.293859,"twenty":-19.188375,"median":-14.537794,"eighty":-10.741285,"marketCap":9164448904},{"date":"2025-03-07","current":-22.14423,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9066903836},{"date":"2025-03-14","current":-22.191243,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9114778716},{"date":"2025-03-21","current":-23.812142,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9768869264},{"date":"2025-03-28","current":-23.159015,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9451698184},{"date":"2025-04-04","current":-21.461559,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":8981925924},{"date":"2025-04-11","current":-20.283953,"twenty":-19.188375,"median":-14.537794,"eighty":-10.741285,"marketCap":8577383188},{"date":"2025-04-17","current":-22.013296,"twenty":-19.188375,"median":-14.537794,"eighty":-10.741285,"marketCap":9464265340},{"date":"2025-04-25","current":-22.471506,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9647004585},{"date":"2025-05-02","current":-26.133782,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":10069079824},{"date":"2025-05-09","current":-24.978649,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9622933758},{"date":"2025-05-16","current":-24.886372,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9511242765},{"date":"2025-05-23","current":-25.065112,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9662780275},{"date":"2025-05-30","current":-25.437176,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":9875295030},{"date":"2025-06-06","current":-27.397906,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":10719316700},{"date":"2025-06-13","current":-26.093952,"twenty":-19.172482,"median":-14.537399,"eighty":-10.741039,"marketCap":10319040329},{"date":"2025-06-20","current":-26.303205,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":10306361892},{"date":"2025-06-27","current":-26.122714,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":10441598554},{"date":"2025-07-03","current":-26.245325,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":10547366785},{"date":"2025-07-11","current":-26.7623,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":10687247467},{"date":"2025-07-18","current":-27.099217,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":10730241097},{"date":"2025-07-25","current":-25.342939,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":10191912410},{"date":"2025-08-01","current":-26.88084,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":10506189788},{"date":"2025-08-08","current":-29.005669,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":11526531562},{"date":"2025-08-15","current":-36.809961,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":11628868512},{"date":"2025-08-22","current":-37.076196,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":11674889862},{"date":"2025-08-29","current":-37.131841,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":11741499711},{"date":"2025-09-05","current":-38.012682,"twenty":-19.10408,"median":-14.536665,"eighty":-10.740548,"marketCap":11997644857},{"date":"2025-09-12","current":-37.58893,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":11969789829},{"date":"2025-09-19","current":-37.774178,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":12072732322},{"date":"2025-09-26","current":-36.292828,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":11489593373},{"date":"2025-10-03","current":-38.360079,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":12169619375},{"date":"2025-10-10","current":-41.851033,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":13122050964},{"date":"2025-10-17","current":-39.969585,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":12649151236},{"date":"2025-10-24","current":-39.020231,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":12281340337},{"date":"2025-10-31","current":-39.695833,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":12446305358},{"date":"2025-11-07","current":-38.922391,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":12175640527},{"date":"2025-11-14","current":-39.959951,"twenty":-19.133555,"median":-14.537005,"eighty":-10.740794,"marketCap":12613714306},{"date":"2025-11-21","current":-47.63087,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":12803118589},{"date":"2025-11-28","current":-48.017721,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":12972971463},{"date":"2025-12-05","current":-46.912541,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":12743853378},{"date":"2025-12-12","current":-46.898582,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":12840388464},{"date":"2025-12-19","current":-44.628604,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":12207411568},{"date":"2025-12-26","current":-47.378311,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":13002298578},{"date":"2026-01-02","current":-47.619463,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":13028570785},{"date":"2026-01-09","current":-47.200634,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":12813148688},{"date":"2026-01-16","current":-48.809861,"twenty":-19.191355,"median":-14.537005,"eighty":-10.740794,"marketCap":13199231109},{"date":"2026-01-23","current":-51.278492,"twenty":-19.2008,"median":-14.537005,"eighty":-10.740794,"marketCap":14034617713},{"date":"2026-01-30","current":-49.457294,"twenty":-19.473274,"median":-14.537005,"eighty":-10.740794,"marketCap":13746130054},{"date":"2026-02-06","current":-48.579171,"twenty":-19.873914,"median":-14.537005,"eighty":-10.740794,"marketCap":13342861135},{"date":"2026-02-13","current":-49.47185,"twenty":-20.78029,"median":-14.537005,"eighty":-10.740794,"marketCap":13387046047},{"date":"2026-02-20","current":-52.664929,"twenty":-21.348455,"median":-14.537005,"eighty":-10.740794,"marketCap":14130361625},{"date":"2026-02-27","current":-52.256391,"twenty":-21.767802,"median":-14.537005,"eighty":-10.740794,"marketCap":14055477644},{"date":"2026-03-06","current":-55.25027,"twenty":-22.145732,"median":-14.537005,"eighty":-10.740794,"marketCap":14568617053},{"date":"2026-03-13","current":-53.475323,"twenty":-22.286208,"median":-14.537005,"eighty":-10.740794,"marketCap":14056705251},{"date":"2026-03-20","current":-52.239326,"twenty":-22.799748,"median":-14.537005,"eighty":-10.740794,"marketCap":13738141431},{"date":"2026-03-27","current":-51.481844,"twenty":-22.965697,"median":-14.542677,"eighty":-10.740794,"marketCap":13540496827}],"updateTime":1774697515413},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ASND\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622182780","title":"Ascendis Pharma held annual general meeting with 90.16% of shares voted","url":"https://stock-news.laohu8.com/highlight/detail?id=2622182780","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622182780?lang=en_us&edition=fundamental","pubTime":"2026-03-25 04:05","pubTimestamp":1774382748,"startTime":"0","endTime":"0","summary":"Ascendis held its annual general meeting on March 23, 2026.Lars Lüthjohan was elected chairman of the meeting.Shareholders approved the audited annual report and discharged the board and management from liability.A resolution to carry forward the consolidated loss of EUR 228 million through recognition in accumulated deficit was approved.Board members were re-elected and Jean-Jacques Bienaimé was elected as a new non-executive board member, Deloitte was re-elected as auditor, and an authorization for the board to purchase up to nominal DKK 1,000,000 of shares or equivalent ADSs as treasury shares was approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news br","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDLb4Sz6y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1699723380.USD","BK4135","LU0109394709.USD","BK4585","ASND","LU1201861249.SGD","BK4588","LU0889565916.HKD","LU0980610538.SGD","LU0320765992.SGD","LU1571399168.USD","LU0648001328.SGD","BK4139","LU0130517989.USD","BK4559","BK","LU0477156953.USD","LU0130102774.USD"],"gpt_icon":0},{"id":"2621707302","title":"European Equities Traded in the US as American Depositary Receipts Climb in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2621707302","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621707302?lang=en_us&edition=fundamental","pubTime":"2026-03-23 23:10","pubTimestamp":1774278628,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were tracking sharply higher late Monday morning, rising 2.55% to 1,721.67 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by lenders Banco Santander  and Banco Bilbao Vizcaya Argentaria , which rose 7% and 5.1%, respectively. They were followed by biopharmaceutical company DBV Technologies  and internet advertising firm Criteo , which were up 2.8% and 2.7%, respectively.The decliners from continental Europe were led by petroleum refiner Equinor  and medical device maker EDAP TMS , which fell 5.5% and 1.9%, respectively. They were followed by oil and gas company Eni  and pharmaceutical company Ascendis Pharma , which were down 1.4% and 0.3%, respectively.The gainers from the UK were led by cruise line operator Carnival  and biopharmaceutical company Biodexa Pharmaceuticals , which advanced 8.1% and 7.6%, respectively. They were followed by mining company BHP Group  and lender HSBC , whic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["E","BK7511","EQNR","LU0162691827.USD","LU0889565916.HKD","BP","BPH","SAN.AU","BK7507","LU0211326839.USD","LU0300736062.USD","BK4168","HSBC","BCYC","DBVT","EDAP","SAN","BK4585","BDRX","LU0320765646.SGD","BK7142","BK4117","BK7095","LU0211326755.USD","BHP","BK4009","BK4142","LU1162221912.USD","ASND","BHP.AU","LU1829250122.USD","LU0496365809.HKD","LU0072461881.USD","CUK","LU0128525689.USD","BBVA","BK4521","HSBH","SLN","LU0976567544.SGD","LU2236285917.USD","CRTO","BK4201","BK4139","AFG","LU0109394709.USD","LU1267930227.SGD","BK4588","BK4082","LU0300736492.USD"],"gpt_icon":0},{"id":"2620636293","title":"Ascendis Pharma A/S EVP and CFO Scott Thomas Smith files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620636293","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620636293?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:14","pubTimestamp":1773872050,"startTime":"0","endTime":"0","summary":"Ascendis Pharma reported an initial statement of beneficial ownership for Scott Thomas Smith, EVP and Chief Financial Officer. Smith beneficially owned 2,517 ordinary shares. He also reported warrants covering 45,000 ordinary shares with an exercise price of USD 37.18. He reported an additional warrant position covering 45,000 ordinary shares with an exercise price of USD 62.17.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLb3SCcz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0980610538.SGD","BK4139","ASND","LU0109394709.USD","LU0477156953.USD","BK4559","LU0130517989.USD","LU1571399168.USD","LU1699723380.USD","LU0648001328.SGD","LU1201861249.SGD","BK","BK4588","BK4585","LU0130102774.USD","LU0320765992.SGD","BK4135"],"gpt_icon":0},{"id":"2620029350","title":"Ascendis Pharma A/S files Form 3 for SVP and PAO Mads Bodenhoff","url":"https://stock-news.laohu8.com/highlight/detail?id=2620029350","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620029350?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:13","pubTimestamp":1773871989,"startTime":"0","endTime":"0","summary":"Ascendis Pharma reported an initial statement of beneficial ownership for Mads Bodenhoff, an officer with the title SVP and PAO. The filing listed warrants covering 30,000 ordinary shares with an exercise price of USD 125. It also reported warrants covering 3,117 ordinary shares at USD 140. The filing included restricted stock units for 2,634 ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLbsMvFQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","LU1201861249.SGD","LU0320765992.SGD","BK4135","LU0980610538.SGD","LU1699723380.USD","LU0477156953.USD","LU0130517989.USD","BK","BK4588","ASND","LU0109394709.USD","LU1571399168.USD","LU0648001328.SGD","BK4139","BK4585","LU0130102774.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2620529293","title":"Ascendis Pharma Director Lisa Morrison Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620529293","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620529293?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:11","pubTimestamp":1773871914,"startTime":"0","endTime":"0","summary":"Ascendis Pharma reported an initial statement of beneficial ownership by director Lisa Morrison. Morrison reported direct ownership of 1,572 ordinary shares. She also reported warrants covering 5,105 ordinary shares with an exercise price of USD 23. Morrison reported additional warrants covering 6,420 ordinary shares with an exercise price of USD 176. She reported restricted stock units covering 2,070 ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the informat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL8Rq2PW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4585","LU1699723380.USD","LU0130517989.USD","LU0320765992.SGD","LU0980610538.SGD","BK4559","LU0648001328.SGD","ASND","LU1201861249.SGD","BK","LU0109394709.USD","LU0130102774.USD","BK4588","LU0477156953.USD","LU1571399168.USD","BK4139","BK4135"],"gpt_icon":0},{"id":"2620293549","title":"Ascendis Pharma A/S director Lars Holtug files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620293549","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620293549?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:10","pubTimestamp":1773871856,"startTime":"0","endTime":"0","summary":"Ascendis Pharma reported an initial statement of beneficial ownership by director Lars Holtug. Holtug reported direct ownership of 4,236 ordinary shares. He also reported warrants for 35,000 ordinary shares with an exercise price of USD 61. The filing listed additional warrants for 7,500 ordinary shares at USD 108. Holtug reported restricted stock units covering 1,374 ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL4vTv3F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130517989.USD","BK4559","BK4588","LU1571399168.USD","LU0109394709.USD","LU0477156953.USD","LU1201861249.SGD","BK4585","ASND","LU0980610538.SGD","LU1699723380.USD","LU0648001328.SGD","BK4135","BK","LU0320765992.SGD","LU0130102774.USD","BK4139","LU0889565916.HKD"],"gpt_icon":0},{"id":"2620541293","title":"Ascendis Pharma A/S files Form 3 for EVP and Head of Research and Product Development Kennett Sprogoe","url":"https://stock-news.laohu8.com/highlight/detail?id=2620541293","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620541293?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:10","pubTimestamp":1773871827,"startTime":"0","endTime":"0","summary":"Ascendis Pharma reported an initial statement of beneficial ownership for Kennett Sprogoe, EVP and Head of Research and Product Development. Sprogoe reported direct ownership of 19,460 ordinary shares. He also reported indirect ownership of 110 ordinary shares held by children. The filing listed warrants covering 114,572 ordinary shares. It also listed restricted stock units covering 16,995 ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contain","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL1bxSCV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK","LU0130517989.USD","LU1699723380.USD","BK4135","BK4139","LU1571399168.USD","BK4585","LU0130102774.USD","LU0477156953.USD","LU0980610538.SGD","LU0320765992.SGD","BK4588","LU0648001328.SGD","LU1201861249.SGD","BK4559","LU0109394709.USD","ASND","LU0889565916.HKD"],"gpt_icon":0},{"id":"2620293319","title":"Ascendis Pharma EVP and President US Market Jay Donovan Wu files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620293319","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620293319?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:07","pubTimestamp":1773871620,"startTime":"0","endTime":"0","summary":"Jay Donovan Wu, EVP and President of the US Market at Ascendis Pharma, filed an initial statement of beneficial ownership. He reported direct ownership of 1,068 ordinary shares. He also reported warrants for 45,078 ordinary shares with an exercise price of USD 132. He reported restricted stock units covering 3,333 ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL85SMH1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156953.USD","BK4559","LU0648001328.SGD","LU0130517989.USD","LU0980610538.SGD","ASND","BK4588","BK4135","LU1201861249.SGD","LU1571399168.USD","LU0889565916.HKD","LU0109394709.USD","LU0130102774.USD","BK4585","BK","LU1699723380.USD","BK4139","LU0320765992.SGD"],"gpt_icon":0},{"id":"2620293310","title":"Ascendis Pharma A/S director Jan Moller Mikkelsen files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620293310","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620293310?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:06","pubTimestamp":1773871593,"startTime":"0","endTime":"0","summary":"Ascendis Pharma reported an initial statement of beneficial ownership for Jan Moller Mikkelsen, a director. Mikkelsen reported direct beneficial ownership of 384,933 ordinary shares. He also reported indirect beneficial ownership of 68,470 ordinary shares held by Cadenza Partners. Mikkelsen reported warrants covering 200,000 ordinary shares at an exercise price of USD 37.18. He also reported restricted stock units covering 15,825 ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL72P2nz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1699723380.USD","LU1571399168.USD","BK","BK4135","ASND","LU0109394709.USD","LU0477156953.USD","LU0980610538.SGD","BK4139","BK4588","LU0320765992.SGD","LU0889565916.HKD","BK4585","LU0648001328.SGD","LU0130517989.USD","LU1201861249.SGD","BK4559","LU0130102774.USD"],"gpt_icon":0},{"id":"2620824293","title":"Ascendis Pharma EVP Flemming Steen Jensen Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620824293","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620824293?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:03","pubTimestamp":1773871437,"startTime":"0","endTime":"0","summary":"Flemming Steen Jensen, EVP of Product Supply and Quality at Ascendis Pharma, filed an initial statement of beneficial ownership. He reported direct ownership of 19,460 ordinary shares. He also reported warrants for 20,000 ordinary shares with an exercise price of USD 62.17. He reported warrants for 27,000 ordinary shares with an exercise price of USD 108. He also reported 4,246 restricted stock units underlying ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL422Swh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0980610538.SGD","LU0477156953.USD","BK4585","BK","LU0648001328.SGD","BK4588","LU1571399168.USD","LU1699723380.USD","BK4135","ASND","LU0130102774.USD","LU0889565916.HKD","LU1201861249.SGD","LU0320765992.SGD","LU0130517989.USD","BK4559","BK4139","LU0109394709.USD"],"gpt_icon":0},{"id":"2620293852","title":"Ascendis Pharma EVP and Chief Medical Officer Aimee Shu files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620293852","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620293852?lang=en_us&edition=fundamental","pubTime":"2026-03-19 06:01","pubTimestamp":1773871313,"startTime":"0","endTime":"0","summary":"Ascendis Pharma reported an initial statement of beneficial ownership for Aimee Shu, EVP and Chief Medical Officer. The filing showed 0 ordinary shares held directly. It reported restricted stock units covering 6,532 ordinary shares. It also reported restricted stock units covering 3,197 ordinary shares. A third restricted stock unit position covered 9,552 ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLyMsG8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASND","BK4135","LU1201861249.SGD","LU0320765992.SGD","LU1571399168.USD","LU0648001328.SGD","LU0477156953.USD","LU0130517989.USD","BK4559","BK4139","LU0889565916.HKD","LU0130102774.USD","LU1699723380.USD","BK4588","BK4585","LU0109394709.USD","LU0980610538.SGD","BK"],"gpt_icon":0},{"id":"2620427321","title":"Ascendis Pharma’s TransCon shows efficacy and safety in Turner Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2620427321","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620427321?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:56","pubTimestamp":1773752183,"startTime":"0","endTime":"0","summary":"Ascendis Pharma (ASND) announced positive Week 52 topline results from New InsiGHTS, its Phase 2 randomized, open-label, active-controlled trial in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ascendis-pharmas-transcon-shows-efficacy-and-safety-in-turner-syndrome-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ascendis-pharmas-transcon-shows-efficacy-and-safety-in-turner-syndrome-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","BK4585","ASND","LU0109394709.USD","BK4139","LU0320765992.SGD"],"gpt_icon":0},{"id":"2620142238","title":"Ascendis reports 9.05 cm/year height velocity at week 52 for TransCon hGH in Turner syndrome Phase 2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2620142238","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620142238?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:33","pubTimestamp":1773750804,"startTime":"0","endTime":"0","summary":"Ascendis reported Week 52 topline results from the Phase 2 New InsiGHTS randomized, open-label trial comparing once-weekly TransCon hGH  with daily somatropin in prepubertal children with Turner syndrome. The study randomized 49 children aged 1 to 10 years, with dosing individualized based on IGF-1. At Week 52, least-squares mean annualized height velocity was 9.05 cm/year with TransCon hGH versus 9.04 cm/year with daily somatropin. Mean dose at Week 52 was 0.22 mg/kg/week for TransCon hGH and 0.29 mg/kg/week for daily somatropin. Safety follow-up extended to 143 weeks, and the company reported no occurrences of slipped capital femoral epiphysis.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL95bqKh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2210150020.SGD","BK4559","BK4588","IE00B3QW5Z07.USD","IE00BN0W2V16.EUR","SG9999014021.USD","SG9999014005.SGD","SG9999014039.USD","LU2210149790.SGD","NDAQ","LU0477156953.USD","IE00BGHQF748.EUR","LU0314104364.USD","LU0130102774.USD","LU0889565916.HKD","LU0130517989.USD","BK4585","IE00BKPKM429.USD","LU1201861249.SGD","BK","IE00BN0W2W23.USD","LU0320765992.SGD","SG9999014013.SGD","LU0648001328.SGD","BK4139","LU2095319765.USD","LU0109394709.USD","BK4135","LU1699723380.USD","LU0980610538.SGD","IE00BN0W2T93.GBP","ASND","LU1571399168.USD","BK4112"],"gpt_icon":0},{"id":"2620493225","title":"Ascendis Pharma Coverage Assumed by Jefferies at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2620493225","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620493225?lang=en_us&edition=fundamental","pubTime":"2026-03-17 02:21","pubTimestamp":1773685260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ASND/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 16, 2026 14:21 ET (18:21 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4139","LU0889565916.HKD","ASND","BK4585","LU0320765992.SGD"],"gpt_icon":0},{"id":"2619466227","title":"Ascendis Pharma assumed with a Buy at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2619466227","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619466227?lang=en_us&edition=fundamental","pubTime":"2026-03-16 21:27","pubTimestamp":1773667622,"startTime":"0","endTime":"0","summary":"Jefferies assumed coverage of Ascendis Pharma (ASND) with a Buy rating and $290 price target The companyhas three approved products powered by its ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ascendis-pharma-assumed-with-a-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ascendis-pharma-assumed-with-a-buy-at-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","BK4585","BK4139","LU0109394709.USD","LU0889565916.HKD","ASND"],"gpt_icon":0},{"id":"2619071468","title":"Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Stevanato Group (STVN) and BioNTech SE (BNTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2619071468","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619071468?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:40","pubTimestamp":1773664806,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ascendis Pharma (ASND – Research Report), Stevanato Group (STVN –...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ascendis-pharma-asnd-stevanato-group-stvn-and-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ascendis-pharma-asnd-stevanato-group-stvn-and-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["STVN","BK4551","LU0109394709.USD","BK4539","HCSG","LU0889565916.HKD","BK4581","BK4139","LU0029874061.USD","XBI","LABU","LU0320765992.SGD","ASND","BK4568","XLV","BNTX","BK4137","BK4548","BK4121","BK4535","BK4585","LU0128526141.USD","BK4588"],"gpt_icon":0},{"id":"2619468793","title":"Ascendis Pharma A/S Publishes ApproaCH Trial Week 104 Data Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2619468793","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619468793?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:29","pubTimestamp":1773664178,"startTime":"0","endTime":"0","summary":"Ascendis published a document summarizing Week 104 results from the pivotal ApproaCH trial open-label extension evaluating once-weekly navepegritide  in treatment-nave children with achondroplasia aged 2 to 11 years. In the double-blind period, annualized growth velocity at Week 52 was 5.89 cm/year for navepegritide and 4.41 cm/year for placebo. The document also reports a least squares mean difference of 1.49 cm/year  for the Week 52 annualized growth velocity endpoint.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascendis Pharma A/S published the original content used to generate this news brief on March 16, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDLbv1sgW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASND","LU1201861249.SGD","LU0477156953.USD","BK4135","LU0109394709.USD","LU0980610538.SGD","LU0130517989.USD","LU0648001328.SGD","BK","BK4588","LU0320765992.SGD","LU0889565916.HKD","LU1699723380.USD","LU1571399168.USD","LU0130102774.USD","BK4585","BK4139","BK4559"],"gpt_icon":0},{"id":"2616804340","title":"RBC Lifts Price Target on Ascendis Pharma to $275 From $250, Keeps Outperform, Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2616804340","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616804340?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:43","pubTimestamp":1772541821,"startTime":"0","endTime":"0","summary":"Ascendis Pharma (ASND)  has an average rating of buy and mean price target of $284.52, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","ASND","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","BK4139"],"gpt_icon":0},{"id":"2616473173","title":"RBC Capital Sticks to Their Buy Rating for Ascendis Pharma (ASND)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616473173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616473173?lang=en_us&edition=fundamental","pubTime":"2026-03-03 20:19","pubTimestamp":1772540354,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Luca Issi maintained a Buy rating on Ascendis Pharma yesterday and set a price target of $275.00. The company’s shares closed y...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-ascendis-pharma-asnd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-ascendis-pharma-asnd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASND"],"gpt_icon":0},{"id":"2616330501","title":"Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Intellia Therapeutics (NTLA) and Immunic (IMUX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2616330501","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616330501?lang=en_us&edition=fundamental","pubTime":"2026-03-02 21:31","pubTimestamp":1772458262,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ascendis Pharma (ASND – Research Report), Intellia T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ascendis-pharma-asnd-intellia-therapeutics-ntla-and-immunic-imux-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ascendis-pharma-asnd-intellia-therapeutics-ntla-and-immunic-imux-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU1861559042.SGD","BK4556","LU0320765992.SGD","LU0889565916.HKD","XBI","NTLA","BK4581","BK4585","IMUX","LU0128526141.USD","ASND","LU1861558580.USD","BK4535","HCSG","LU0029874061.USD","XLV","LABU","BK4139","LU0109394709.USD","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":132,"code":"91000000","status":"200"}]}}